Cosmo Artificial Intelligence – AI Ltd. (a subsidiary of Cosmo Pharmaceuticals N.V.)

Dublin, Ireland  All Ireland companies →
Biotech / Drug Discovery Clinical AI Platform Medical Device / Hardware
Colorectal Surgery Gastroenterology
Gastroenterology AI
Claim this company

Products

GI Genius System 100 and GI Genius System 200
Cosmo Pharmaceuticals
Gastroenterology AI
The GI Genius System 100 and 200 are FDA-cleared, AI-powered computer-assisted detection (CADe) systems that enhance real-time identification of colonic mucosal lesions, such as polyps and adenomas, during endoscopy.

See all 1 product →

About Cosmo Artificial Intelligence – AI Ltd. (a subsidiary of Cosmo Pharmaceuticals N.V.)

Cosmo Artificial Intelligence – AI Ltd. (a subsidiary of Cosmo Pharmaceuticals N.V.) is a healthcare AI company focused on developing medical-grade AI systems that operate in real clinical environments and support physicians during procedures. The company aims to reshape medicine through artificial intelligence, with a particular emphasis on MedTech AI, dermatology, and gastrointestinal diseases.

Cosmo AI’s flagship product is the GI Genius™ platform, a real-time AI system for GI endoscopy. This platform, which includes the ColonPRO™ US software, aids endoscopists in detecting colonic mucosal lesions like polyps during colonoscopies. The GI Genius™ system was the first real-time AI system in healthcare to introduce colorectal polyp detection in 2019 and received the FDA’s first De Novo clearance for an AI GI device in 2021. It has since supported over 4 million patients worldwide. The company is also expanding its AI-driven clinical innovation to other gastrointestinal indications, such as the detection of early neoplasia in Barrett’s esophagus, through strategic R&D collaborations.

Focus Areas

MedTech AI real-time AI systems for medical procedures gastrointestinal diseases (specifically colorectal cancer screening and Barrett's esophagus) dermatology computer-aided detection (CADe) workflow optimization and personalized care experiences.

Business Intelligence

TechnologyGI Genius™ intelligent endoscopy system, ColonPRO™ software, AI Access™ platform, NVIDIA Holoscan and IGX technologies

What Physicians Need to Know

MedTech AI & Real-time AI Systems for Medical Procedures
Cosmo AI specializes in real-time AI systems that operate during medical procedures, assisting physicians with detection, decision support, and workflow optimization. Their flagship product, GI Genius™, is the first real-time AI system in healthcare for colorectal polyp detection, receiving the FDA's first De Novo clearance for an AI GI device in 2021. It has supported over 4 million patients worldwide. The GI Genius™ ecosystem, built on NVIDIA IGX, provides low-latency AI inference for various AI applications. Cosmo's engineering teams leverage advanced accelerated computing technologies from NVIDIA to develop these real-time AI systems.
Gastrointestinal Diseases (Colorectal Cancer Screening & Barrett's Esophagus)
Cosmo's primary focus in GI is colorectal cancer screening with their ColonPRO™ application, which is part of the GI Genius™ ecosystem. ColonPRO™ aims to reduce the miss rate in colonoscopy through polyp detection (CADe), characterization (CADx), sizing (CADs), and Computer Aided Quality (CAQ) reporting. Clinical trials have shown that GI Genius™ can cut missed polyp rates by up to 50% and significantly improve diagnostic performance. They are also expanding into upper gastrointestinal indications, with a strategic R&D collaboration to develop an AI-based computer-aided detection (CADe) system for early neoplasia in Barrett's esophagus.
Computer-Aided Detection (CADe)
A core specialization is Computer-Aided Detection (CADe), exemplified by their GI Genius™ system and ColonPRO™ software, which assist endoscopists in real-time detection of colorectal mucosal lesions during colonoscopies. This technology uses deep learning algorithms to provide visual markers and alerts to physicians.
Workflow Optimization
Cosmo's AI systems are designed to simplify workflows and reduce administrative burdens. An example is the Intelligent Tablet, a voice-enabled, AI-driven reporting assistant that captures procedure notes in real-time and streams them directly into the EMR, aiming to slash documentation time.
Personalized Care Experiences
Cosmo's work in AI and intelligent systems is focused on supporting more personalized care experiences. This aligns with the broader trend of AI in healthcare to enhance patient care and outcomes through improved efficiency and organization.
Physician Tip

Cosmo AI's GI Genius™ system, with its ColonPRO™ software, offers real-time assistance during colonoscopies, significantly improving polyp detection rates and reducing missed lesions. This can lead to more accurate diagnoses and potentially save lives by detecting precancerous polyps earlier. The system is designed for seamless integration with existing endoscopy equipment, requiring no major workflow changes. Physicians can expect enhanced decision support, improved diagnostic performance, and reduced documentation time through AI-driven reporting assistants. The ongoing development in Barrett's esophagus detection also indicates future tools for early neoplasia identification in upper GI endoscopy.

The GI Genius™ intelligent endoscopy module is designed for seamless integration with all major endoscopic processors and existing endoscopy towers and high-definition endoscopes. It simply connects to the existing endoscope, video processor, and display monitor. Cosmo is also exploring advanced integrations, such as GI Genius™ XR, an app for Apple Vision Pro, which allows physicians to access GI Genius™ platform AI features in a spatial computing environment. The GI Genius™ AI Access developer kit and Innovation Center provide a platform for developers and startups to build, test, and refine real-time AI solutions for medical procedures, enabling faster innovation and integration of third-party AI applications.

Products by Cosmo Artificial Intelligence – AI Ltd. (a subsidiary of Cosmo Pharmaceuticals N.V.)

1 product in the directory

GI Genius System 100 and GI Genius System 200
Cosmo Pharmaceuticals
Gastroenterology AI
The GI Genius System 100 and 200 are FDA-cleared, AI-powered computer-assisted detection (CADe) systems that enhance real-time identification of colonic mucosal lesions, such as polyps and adenomas, during endoscopy.

What the Web Says

Cosmo Artificial Intelligence - AI Ltd., a subsidiary of Cosmo Pharmaceuticals N.V., offers AI-powered solutions primarily focused on video creation, customer engagement, and healthcare technology. Product reviews highlight its ease of use for converting text into professional videos, efficient setup, and responsive customer support. However, users also note limitations in customization, buggy features, and restricted functionality. As an employer, there's limited information, but general sentiment suggests a fast-paced environment with some concerns about work-life balance and management.

Overall: Mixed

Strengths

  • Ease of use for video creation and text-to-video conversion.
  • Efficient and easy setup with seamless integration.
  • Responsive and helpful customer support.
  • Affordable pricing for branded video production.
  • Effective for engaging customers with real-time replies and automated notifications.
  • Provides detailed reports for business insights.

Limitations

  • Limited customization options for visuals and video flows.
  • Buggy features that can lead to mismatched visuals and tone.
  • Limited functionality requiring manual adjustments for custom projects.
  • Missing features for specific visuals and branding.
  • Mobile version shows fewer features.
  • Work-life balance and management concerns (employer review).

Based on reviews from: G2, Google Play, Reddit, Indeed.com, Capterra, YouTube, PR Newswire, Trustpilot

Last updated: 2026-10-19

Videos

News, demos, and interviews about Cosmo Artificial Intelligence – AI Ltd. (a subsidiary of Cosmo Pharmaceuticals N.V.).

Loading videos...

Videos load interactively. If none appear, search YouTube for Cosmo Artificial Intelligence – AI Ltd. (a subsidiary of Cosmo Pharmaceuticals N.V.) →

View all on YouTube

Press & Coverage

Nasdaq
Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms
Cosmo Pharmaceuticals N.V. reported strong preliminary unaudited 2025 revenue and year-end cash, highlighting the evolution of GI Genius™ into a scalable AI platform and the regulatory approval of ColonPRO in Europe in 2025.
2026-01
Nasdaq
Cosmo Highlights Leadership in Real Time Medical AI at NVIDIA GTC 2026
Cosmo Pharmaceuticals N.V. announced its participation at NVIDIA GTC 2026, where it presented a technical session on "Engineering Medical Grade Platforms for Real Time AI," showcasing its work in developing AI systems for clinical environments.
2026-03
FirstWord HealthTech
Cosmo Announces Strategic R&D Collaboration to Advance AI-Based Detection of Early Neoplasia in Barrett's Esophagus
Cosmo announced a strategic R&D collaboration to advance AI-based detection of early neoplasia in Barrett's Esophagus, aiming to strengthen the GI Genius™ platform and support future regulatory submissions in Europe and the United States.
2026-03
Medical Product Outsourcing
Cosmo Intelligent Medical Devices Wins FDA Nod for GI Genius Hardware
Cosmo Intelligent Medical Devices received FDA 510(k) clearance for its next-generation GI Genius hardware, which includes enhanced AI capabilities and the FDA-cleared ColonPRO software for polyp detection.
2024-08
Investing News Network
Medtronic and Cosmo Pharmaceuticals forge ahead in AI-driven care
Medtronic and Cosmo Pharmaceuticals expanded their partnership to further capitalize on the GI Genius™ intelligent endoscopy module, with Medtronic paying Cosmo $100 million upfront and potential milestone payments.
2023-12
FirstWord Pharma
Cosmo Unveils Bold 2030 Vision and Strategy; launches AI-driven Growth Phase at Investor Day 2025
Cosmo N.V. announced its Vision 2030, outlining a strategic plan for transformational growth driven by AI and digital platforms, aiming for €480 million in recurring revenues by 2030.
2025-07
Medical Design & Outsourcing
AI tips for device developers from Medtronic partner Cosmo Intelligent Medical Devices
Cosmo Intelligent Medical Devices, a division of Cosmo Pharmaceuticals, shared insights and best practices for AI device developers, drawing from their experience in developing the GI Genius system with Medtronic.
2024-08
AI Device Index
Cosmo Artificial Intelligence - AI Ltd: 6 FDA-listed AI devices
Cosmo Artificial Intelligence - AI Ltd has 6 AI-enabled medical devices listed on the FDA's AI-enabled device list.
unknown

Frequently Asked Questions

Cosmo Artificial Intelligence specializes in real-time AI systems for medical procedures, with a strong focus on gastrointestinal diseases. Their products include computer-aided detection (CADe) solutions designed to enhance the accuracy and efficiency of colorectal cancer screening and the detection of Barrett's esophagus during endoscopic procedures. These AI tools aim to assist physicians in identifying subtle abnormalities that might otherwise be missed.
Cosmo AI's real-time systems are designed for seamless integration into current clinical workflows. For gastroenterology, their AI can be integrated with existing endoscopy equipment to provide immediate analysis during procedures. In dermatology, the AI tools can assist with real-time analysis of skin lesions, aiming to optimize diagnostic pathways and support personalized care experiences by providing instant, data-driven insights to physicians.
Cosmo Artificial Intelligence prioritizes regulatory compliance for all its MedTech AI solutions. They adhere to stringent medical device regulations and data privacy standards, such as GDPR and HIPAA. The company actively pursues necessary certifications and approvals from relevant health authorities to ensure their products are safe, effective, and legally compliant for clinical use.
Cosmo Artificial Intelligence offers flexible pricing structures tailored to the specific needs of healthcare institutions, which may include subscription models or per-procedure fees. Their support models encompass comprehensive training for healthcare providers, ongoing technical assistance, and regular software updates to ensure optimal performance and user proficiency. Specific details can be obtained through direct consultation with their sales team.
As a subsidiary of Cosmo Pharmaceuticals N.V., Cosmo Artificial Intelligence benefits from the financial stability and established presence of its parent company. They are committed to continuous innovation in MedTech AI, actively seeking strategic partnerships with leading healthcare providers and research institutions to expand their product portfolio and enhance personalized care experiences. Their long-term vision includes further advancements in AI for various medical specialties.
Cosmo AI's solutions enhance workflow optimization by automating and streamlining aspects of medical procedures, reducing the burden on physicians and improving efficiency. By providing real-time, data-driven insights, their AI tools enable more precise diagnoses and tailored treatment plans, thereby contributing significantly to personalized care experiences for patients across various medical disciplines.
Yes, Cosmo Artificial Intelligence is actively developing and offering AI solutions for dermatology, particularly in the area of computer-aided detection (CADe). These tools are designed to assist dermatologists in the early and accurate identification of various skin conditions, including suspicious lesions, aiming to improve diagnostic precision and support timely intervention. Specific product details are available upon request.

Related Companies

CapsoVision
Saratoga, California, United States [1, 2, 11, 13, 17, 19]

CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (AI) technologies for capsule endoscopy solutions. Their primary goal is to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. [7] Their flagship product, the CapsoCam Plus system, is a single-use capsule endoscope equipped with four cameras, providing […]
Co
Cosmo Artificial Intelligence – AI
Dublin, Ireland

Cosmo Artificial Intelligence (Cosmo AI) is a life sciences company specializing in MedTech AI, dermatology, and gastroenterology. The company focuses on developing and manufacturing innovative, high-quality products and technologies, particularly those supported by AI and digital health, to enhance healthcare delivery. Cosmo AI’s mission is to empower patients, healthcare professionals, and partners by innovating at […]
Exact Sciences
Madison, Wisconsin, U.S.

Exact Sciences is a molecular diagnostics company dedicated to the early detection and prevention of cancer, as well as guiding treatment decisions. The company is best known for its non-invasive colorectal cancer screening test, Cologuard, which analyzes stool samples for DNA markers and occult hemoglobin to assess a patient’s risk of colorectal cancer. Cologuard was […]
Di
Digestaid – Artificial Intelligence Development SA
Porto, Portugal

Digestaid – Artificial Intelligence Development SA is a healthcare AI company focused on developing advanced deep learning solutions for the detection of digestive lesions. The company aims to revolutionize gastrointestinal practice by applying AI technologies across digestive and pancreatobiliary tracts, as well as functional tests. Their solutions are designed to overcome diagnostic limitations of current […]
Motus GI
Fort Lauderdale, Florida, United States

Motus GI Holdings, Inc. is a medical technology company that develops innovative solutions for gastrointestinal procedures, primarily focusing on enhancing colonoscopy outcomes. Their flagship product, the Pure-Vu System, is a U.S. FDA-cleared and CE-marked medical device designed to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper GI endoscopy procedures. The […]
Ambu
Ballerup, Denmark

Ambu is a global MedTech company that has been innovating healthcare solutions for over 85 years, with a strong focus on single-use medical devices. The company’s mission is to improve patient care through practical innovation, patient safety, and workflow efficiency. Ambu is particularly recognized for its pioneering work in single-use endoscopy, offering a comprehensive portfolio […]
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.